COVID-19 Clinical Neuroscience Study (COVID-CNS)
Addressing the urgent need to understand the biological causes of neurological and neuropsychiatric complications in hospitalised COVID-19 patients.
Tel: 0207 848 7297
Email: covidcns@kcl.ac.uk
About the study
The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a £2.3m UKRI study jointly led by researchers at the University of Liverpool and King's College London. Acute neurological and neuropsychiatric complications of COVID-19 affect up to 20-30% of hospitalised patients. In collaboration with CoroNerve and ISARIC-4C study, we will identify these patients, and those that have received the COVID-19 vaccination, and invite them to join COVID-CNS, part of the COVID-19 section of the NIHR BioResource.
- Advanced materials
- Infectious diseases
- Personalised health
- Heritage
- Digital
- Starting well, living well, ageing well
- Climate futures
Discover research at Liverpool:
Funders and collaborators
Watch the COVID-CNS team discuss the study
The study looks to investigate what is driving brain complications in patients with COVID-19 and why do some people develop neurological or neuropsychiatric symptoms whilst others do not.
Publications
Publications
The COVID-CNS team are actively producing papers for journals with impact; take a look at the most recent articles.
Working groups
Working groups
COVID-CNS has six working groups focusing on different research areas of brain complications associated with COVID-19.
Patient and public involvement
Patient and Public Involvement (PPI)
Our PPI panel are helping to shape our research study by sharing the patient’s perspective on COVID-CNS. Find out more from the PPI team.